Vimarsana
Biggest News Aggregation in the World

Page 37 - Processing Technology News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Processing Technology. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Processing Technology Today - Breaking & Trending Today

Gannex doses first subject in Phase II primary biliary cholangitis trial - Vimarsana News

Gannex doses first subject in Phase II primary biliary cholangitis trial

Gannex Pharma has dosed the first subject in Phase II trial of ASC42 for the treatment of primary biliary cholangitis (PBC) patients.

NeuroSense previews Phase IIb trial plans for oral ALS drug - Vimarsana News

NeuroSense previews Phase IIb trial plans for oral ALS drug

NeuroSense CEO Alon Ben-Noon reveals the target patient population and outcome measures of a planned Phase IIb ALS trial of PrimeC.

Cotton Industry Sets Voluntary Wrap Standards - AG INFORMATION NETWORK OF THE WEST - Vimarsana News

Cotton Industry Sets Voluntary Wrap Standards - AG INFORMATION NETWORK OF THE WEST

The standard was created to address inferior wrap that was beginning to come into the marketplace.

Source: aginfo.net
Akston to launch Phase II trial of Covid-19 booster vaccine in Netherlands - Vimarsana News

Akston to launch Phase II trial of Covid-19 booster vaccine in Netherlands

Akston Biosciences is set to commence a Phase II trial of its protein subunit Covid-19 vaccine, AKS-452, as a booster in the Netherlands.

Brazil accounts for 1.7% share of global clinical trial activity in 2021 - Vimarsana News

Brazil accounts for 1.7% share of global clinical trial activity in 2021

Methodology:The clinical trials data used for the analyses were extracted from the Clinical Trials Database of GlobalData’s Pharma Intelligence Center. Clinical Trials are sourced from numerous government, non-government and company clinical trial registries worldwide alongside clinical research publications, scientific conferences, company websites, SEC filings and more. The information is gathered by a combination of automation and secondary research to ensure accuracy and validity. A small number of Phase 0, Phase I/II, Phase II/III, and Phase III/IV trials were combined with Phase I, ...